Cancer Treatment Centers of America: Clincal Trials
Learn More About This Topic: Chat with Us | Email Us
Sipuleucel-T (Provenge) Registry Study in Men with Advanced Prostate Cancer
The purpose(s) of this study is to learn more about the occurrence of cerebrovascular events reported during or following sipuleucel-T therapy, to learn about the survival of study subjects, to understand the order and timing of anticancer therapies subjects may receive following treatment with sipuleucel-T, and to look at changes in PSA levels following treatment with sipuleucel- T and other anticancer therapies.
For More Information:
Please contact one of our Oncology Information Specialists at 1-800-615-3055 to learn more about this clinical trial. Oncology Information Specialists are available 24 hours a day, 7 days a week, 365 days a year.